3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Diabetes Mellitus, Type 2
1
Colorectal Neoplasms
1
Interventions
Pioglitazone
4
Sitagliptin Phosphate
3
Resistance Training
3
Vildagliptin
2
Sulfonylurea Compounds
2
Nutritional Status
2
Metformin
2
Dipeptidyl-Peptidase IV Inhibitors
2
Blood Specimen Collection
2
voglibose
1
saxagliptin
1
repaglinide
1
miglitol
1
metahexamide
1
meglitinide
1
mazdutide
1
glymidine
1
glisoxepide
1
gliquidone
1
glimepiride
1
glibornuride
1
alogliptin
1
Urine Specimen Collection
1
Troglitazone
1
Tolbutamide
1
Tolazamide
1
Thiazolidinediones
1
Surveys and Questionnaires
1
Sodium-Glucose Transporter 2 Inhibitors
1
Rosiglitazone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Diabetes Mellitus, Type 2
×
Plant Proteins
×
Clear all
NCT03206827
2021-09-27
ScenoProt
University of Helsinki
Phase NA
Completed
147 enrolled